An indicator of appropriate neuroleptic prescribing in nursing homes

被引:49
作者
Oborne, CA
Hooper, R
Li, KC
Swift, CG
Jackson, SHD
机构
[1] Guys Kings & St Thomas Sch Med, Dept Hlth Care Elderly, Clin Age Res Unit, London, England
[2] Guys Kings & St Thomas Sch Med, Dept Publ Hlth Serv, London, England
关键词
nursing homes; antipsychotic agents; prescriptions; drug; quality of health care; quality indicators; health care;
D O I
10.1093/ageing/31.6.435
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: to derive and apply objective criteria which assess the appropriateness of neuroleptic prescribing, in a random sample of nursing homes. Design: cross-sectional survey of prescribing in a random sample of nursing homes. Setting: 22 homes with more than 35 residents in the former South Thames Region. Subjects: 934 nursing home residents aged 65 years or over. Methods: we compared criteria of appropriate neuroleptic prescribing, including appropriate indication and review, to clinical data documented in the nursing and GP notes of residents prescribed neuroleptics. Results: of the 229 (24.5%) residents prescribed neuroleptics, clinical notes were available for 225. Clinical data indicated that only 40/225 (17.8%) residents receiving neuroleptics received appropriate therapy. The intra-cluster correlations for appropriate and inappropriate prescribing of neuroleptics were 0.038 and 0.12 respectively. It was not possible to derive reference ranges of observed prescribing that included homes demonstrating appropriate prescribing whilst excluding those with inappropriate prescribing. Thus, clinical data are needed whenever neuroleptic appropriateness is assessed. Criteria were readily applicable in nursing homes. Conclusion: application of criteria of appropriate neuroleptic prescribing in a random sample of nursing homes identified suboptimal prescribing to elderly residents.
引用
收藏
页码:435 / 439
页数:5
相关论文
共 23 条
[1]   A RANDOMIZED TRIAL OF A PROGRAM TO REDUCE THE USE OF PSYCHOACTIVE-DRUGS IN NURSING-HOMES [J].
AVORN, J ;
SOUMERAI, SB ;
EVERITT, DE ;
ROSSDEGNAN, D ;
BEERS, MH ;
SHERMAN, D ;
SALEMSCHATZ, SR ;
FIELDS, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) :168-173
[2]  
BAZIRE S, 1995, PSYCHOTROPIC DRUG DI, P72
[3]   Optimal management of behavioural disorders associated with dementia [J].
Class, CA ;
Schneider, L ;
Farlow, MR .
DRUGS & AGING, 1997, 10 (02) :95-106
[4]   A COEFFICIENT OF AGREEMENT FOR NOMINAL SCALES [J].
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1960, 20 (01) :37-46
[5]  
*COMM SAF MED, 2001, CURRENT PROBLEMS PHA, V1, P4
[6]   MEDICATIONS AND DIAGNOSES IN RELATION TO FALLS IN A LONG-TERM CARE FACILITY [J].
GRANEK, E ;
BAKER, SP ;
ABBEY, H ;
ROBINSON, E ;
MYERS, AH ;
SAMKOFF, JS ;
KLEIN, LE .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1987, 35 (06) :503-511
[7]   PSYCHOTROPIC-DRUG USE IN LONG-TERM CARE FACILITIES - A REVIEW OF THE LITERATURE [J].
HARRINGTON, C ;
TOMPKINS, C ;
CURTIS, M ;
GRANT, L .
GERONTOLOGIST, 1992, 32 (06) :822-833
[8]   Thioridazine dose-related effects on biomechanical force platform measures of sway in young and old men [J].
Liu, YJ ;
Stagni, G ;
Walden, JG ;
Shepherd, AMM ;
Lichtenstein, MJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (04) :431-437
[9]  
Lunn J, 1997, INT J PHARM PRACT, V5, P6
[10]  
McGrath AM, 1996, BRIT MED J, V312, P611